Stay updated on Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial
Sign up to get notified when there's something new on the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page.

Latest updates to the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous funding/operating status notice and Revision: v3.4.1 text.SummaryDifference0.2%

- Check40 days agoChange DetectedA system-wide notice about government funding and operations is now shown, and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check47 days agoChange DetectedA glossary toggle was added; QC-related labels were standardized (Last Update Submitted that Met QC Criteria), and the revision version was updated to v3.4.0, while the No FEAR Act data label was updated from lowercase to uppercase.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.3.4 replaces Revision: v3.3.3 on the page, indicating a minor metadata update. No user-facing study content or interactive features appear to be changed.SummaryDifference0.0%

- Check82 days agoChange DetectedUpdated the Locations section to include additional sites across the U.S. and Canada (Alabama, Arizona, California, Florida, Illinois, Kansas, Kentucky, Louisiana, Maryland, Minnesota, Missouri, Montana, New Jersey, Ohio, Pennsylvania, Rhode Island, Tennessee, Texas, Washington, Alberta, Ontario). The page also shows removal of certain location entries and an updated revision note.SummaryDifference1%

Stay in the know with updates to Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page.